Hemodynamic Monitoring Market - Growth, Trends, and Forecast (2019 - 2024)
|出版商||Mordor Intelligence Pvt Ltd||商品編碼||567952|
|出版日期||內容資訊||英文 118 Pages
|血液循環動態監測的全球市場 Hemodynamic Monitoring Market - Growth, Trends, and Forecast (2019 - 2024)|
|出版日期: 2019年02月01日||內容資訊: 英文 118 Pages||
本報告提供全球血液循環動態監測設備的市場相關分析，全球整體的市場規模趨勢預測 (過去、今後6年份) ，及主要推動及市場的阻礙要素，各系統/產品、各用途、各地區的詳細趨勢，市場競爭環境，主要企業簡介等資訊彙整，為您概述為以下內容。
The global hemodynamic monitoring market was valued at USD 249.06 million in 2018, and is estimated to be valued at USD 312.42 million in 2024, witnessing a CAGR of 3.85%. The key factors propelling the growth of this market are increase in the number of critically ill geriatric cases, rise in the prevalence of cardiac disorders and diabetes, increasing demand for home-based and non-invasive monitoring systems, advances in technology, due to funding by private players and government bodies, and increase in the number of people suffering from hypertension.
As per the scope of the report, critically ill patients require continuous monitoring of their vital parameters. This is done by direct pressure monitoring systems, which are also known as hemodynamic systems. The main function of these systems is to monitor the cardiac activity. The hemodynamic systems give information about blood pressure, blood volume, and fluid balance.
Minimally Invasive Monitoring Systems is Expected to hold its Highest Market Share in the System Segment
In the system segment of the market, minimally invasive monitoring systems are believed to have the largest market size and are expected to witness a CAGR of 8.0% during the forecast period.
The minimally invasive systems help in tracking stroke volume continuously and offer dynamic information of fluid responsiveness. Some of the systems provide the assessment of volumetric preload variables, while others highlight the continuous measurement of central venous saturation with proprietary catheters. These variables of minimally invasive systems, along with cardiac output, deliver improved hemodynamic monitoring.
There is a recent advancement in echocardiography device known as a transesophageal echocardiography device with a miniaturized probe, which is now used for continuous hemodynamic assessment. These monitoring systems have made hemodynamic calculations easier, which has gained the attention of healthcare providers, thus, resulting in the growth of the market.
North America Dominates the Market and is Expected to do the Same in the Forecast Period
North America currently dominates the market for hemodynamic monitoring and is expected to continue its stronghold for a few more years. The United States holds the largest share of the global hemodynamic monitoring market. The growth of the US hemodynamic monitoring market is the most notable, owing to the presence of major market players, technologically advanced hospitals, and an increasing number of critically ill patients being treated in hospitals of the region. In 2016, Cheetah Medical Inc. received FDA approval for 'Starling SV', a non-invasive hemodynamic monitoring system.
With increasing FDA approvals for monitoring devices and new product launches, the US hemodynamic monitoring market is expected to grow during the forecast period.
The hemodynamic monitoring market is highly competitive and consists of several major players. In terms of market share, few of the major players currently dominate the market. However, with technological advancements and product innovations, mid-size to smaller companies are increasing their market presence by introducing new devices with fewer prices. Companies, like Getinge Group, Koninklijke Philips NV, Edwards Life Sciences Corporation, GE Healthcare, and LiDCO Group, hold substantial shares in the market.